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Solution pH is an important factor during drug formulation and processing. Changes in 
pH present challenges. Regulation of pH is typically managed by using a buffer system, 
which must have a suitable pKa. The pKa value of buffers depends on temperature, 
pressure and ionic strength. In addition, the pKa value can also be affected by the polarity 
of the solvent, e.g., by the addition of a co-solvent. Theoretical considerations and 
accessible experimental data were used to understand how the pKa values of 
pharmaceutically relevant buffers depend on these factors. Changes in temperature also 
affect the buffer pKa. Carboxylic acid moieties were least affected by changes in 
temperature. Buffers containing amino groups were most affected by changes in 
temperature, and the pKa decreased as temperature was increased. It was possible to 
predict accurately how buffer pKa varies with temperature, based on changes in enthalpy 
and heat capacity for the ionization reactions. Changes in pressure had a limited effect on 
buffer pKa for pressures <100 MPa. At higher pressures, buffer pKa varied by up to 0.5 
pH units. Altering the ionic strength or polarity of the solvent influenced buffer pKa 
slightly. However, it is possible to keep both the ionic strength and the polarity of the 
solvent constant during drug formulation and processing. 
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Regulation of pH is often essential, e.g., biological and biochemical processes are controlled by 
proton transfer (Fukada and Takahashi, 1998). Energy production in mitochondria by reduction of 
NAD+ to NADH is one example of a biological process governed by proton transfer, and many 
biochemical studies are performed under pH-buffered conditions (Fukada and Takahashi, 1998; 5 
Karow et al., 2013; Mauger, 2017). pH is also an important factor in drug formulation and 
processing, as the pH facilitates folding and unfolding of proteins, chemical degradation and 
solubility of drug compounds (Babic et al., 2007; O’Brien et al., 2012; Stoll and Blanchard, 1990). 
It is estimated that two-thirds of marketed and potential drugs are ionizable compounds (Williams et 
al., 2013). Most ionizable drugs are weak electrolytes, thus their dissociation is partially pH-10 
dependent (Williams et al., 2013). Regulation of pH is used to ensure the quality and performance 
of drug formulations, since pH can improve the overall thermodynamic parameters of reactions, 
chemical stability and solubility. During pharmaceutical processing such as autoclaving, 
homogenization, stability testing and storage, controlling pH can be considered as a critical quality 
attribute in many systems and formulations. 15 
 
Buffer systems are central in the control of pH, making it important to understand buffer properties 
in order to obtain a robust formulation. All weak acids or bases and their corresponding base or acid 
in aqueous solution can be a buffer solution. It is easy to imagine the large numbers of potential 
buffers that exist (Stoll and Blanchard, 2009), though within drug formulation a limited number of 20 
buffers are usually used. In general, buffers can be characterized based on their chemical structure 
as, i) carboxylic acid buffers, ii) phosphate buffers, iii) zwitterionic buffers and iv) Tris-based 
buffers (Mauger, 2017). Buffers should: (1) have a relevant pKa, (2) have a  high aqueous solubility 
to achieve a sufficient buffer capacity, (3) be chemically stable, (4) exhibit minimal toxicity, and (5) 
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be inexpensive, easily purified and accessible (Good et al., 1966; Mauger, 2017; Stoll and 25 
Blanchard, 1990; Yalkowsky, 1999). Selecting a buffer with a relevant pKa is important and it 
should reflect the experimental conditions, i.e., as a general rule buffers are most effective in a 
range of ± 1 pH units of their pKa (Mauger, 2017). 
 
Buffer solutions and their chemistry have been investigated since the beginning of the 1900s. The 30 
pKa of various buffer species vary as a function of temperature, pressure and ionic strength (Fukada 
and Takahashi, 1998; Good et al., 1966; Mauger, 2017; Stoll and Blanchard, 1990). These three 
parameters can all be varied in a drug formulation and during processing of the formulation. It is, 
therefore, important for the pharmaceutical scientist to understand how the pKa of buffers varies 
with these parameters to ensure both a robust formulation during processing, e.g. during 35 
sterilization, and during storage (Karow et al., 2013). To understand the variation of pKa, 
knowledge of thermodynamic data for the ionization of acids and bases is necessary. 
 
The present work aims to provide formulation scientists with an overview of how the pH of the 
buffers used in pharmaceutical drug formulation is influenced by temperature, pressure and ionic 40 
strength based on accessible experimental data and theoretical considerations. 
 
2 Theoretical background 
A buffer solution or buffering agent is an aqueous solution of a weak acid (HA) or base (A-) in 
equilibrium with its corresponding base or acid.  45 
HA  H+ + A-                              (Eq. 1)  
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The equilibrium constant is referred to as the acid dissociation constant Ka or ionization constant. It 
relates to the degree of dissociation of the acid, and generally it is calculated based on the 
concentrations of the reacting species: 
Ka =  
[H+][A−]
[HA]
   (Eq. 2) 50 
So the Ka is a measure of the strength of the acid. Strong acids have a high Ka, which means a high 
degree of dissociation. Most often, acid strengths are reported as pKa values, the negative logarithm 
of Ka. This value is strongly related to the pH of the solution, and the Henderson-Hasselbalch 
equation describes how the pH depends on the concentration of the buffer components and pKa: 
pH =  pKa +  log
[A−]
[HA]
  (Eq. 3) 55 
The buffer pKa depends on temperature, pressure and ionic strength, and the pH of the solution is 
affected accordingly. To understand how such factors influence the pKa, it is important to 
understand the thermodynamics behind the equilibrium constant. ΔG˚ (Gibb’s free energy) is the 
thermodynamic parameter quantifying the energy that drives reactions. At constant temperature (T 
in K) and pressure, ΔG˚ is defined by the change in enthalpy (H) and entropy (S): 60 
ΔG˚ = ΔH˚ − TΔS˚  (Eq. 4) 
 
For a system in chemical equilibrium, ΔG˚ is related to the equilibrium constant: 
ΔG˚ = -RTlnKa  (Eq. 5) 
where R is the gas constant, and T is the temperature. 65 
 
2.1 Theoretical influence of temperature 
Through standard Gibb’s free energy in eq. 4 and 5, the equilibrium constant can be linked to 
enthalpy and entropy: 
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  (Eq. 6) 70 
It is possible to differentiate the expression in equation 7 with respect to T and get the van’t Hoff 





   (Eq. 7) 
Eq. 7 shows that the temperature dependence of Ka is governed by the protonation enthalpy. A large 
absolute value of ΔH means that Ka is strongly temperature dependent. The van’t Hoff equation is 75 









�  (Eq. 8) 
This equation shows the link between Ka and temperature with the assumption that ΔH is a constant 
in the given temperature range. However, ΔH does change with temperature. The change in 
enthalpy as a function of temperature is described by a quantity termed the heat capacity, Cp: 80 
∆Cp =  
∂ΔH
∂T
   (Eq. 9) 
By combining eq. 8 and 9, it is possible to derive an extended van’t Hoff equation: 











� + lnK1  (Eq. 10) 
where the subscripts refer to the values at temperatures 1 and 2. Thus, the correlation between Ka 
and temperature depends on the thermodynamic quantities ΔH and ΔCp, and it possible to calculate 85 
K2 at any temperature T2 as long as K1, ΔH and ΔCp are known at temperature T1. 
 
2.2 Effect of pressure 
For buffers in solution, the effect of pressure on the equilibrium constant is closely related to the 
change in volume (Hayert et al., 1999; Quinlan and Reinhart, 2005; Van Eldik et al., 1989). From a 90 
chemical thermodynamic perspective, the relationship between the pressure and volume of liquids 
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is described by compressibility, which is the decrease in volume upon pressure increase. In 
chemical thermodynamics, the chemical potential is defined as the partial molar Gibb's free energy: 
𝜇𝜇 = ∂G
∂N
   (Eq. 11) 
The chemical potential is affected by composition, temperature and pressure. The variation of 95 
chemical potential of a solute species at constant temperature is a function of the pressure P and the 
volume V of the solute species: 
∂μ
∂P
= V   (Eq. 12) 
By combining eq. 5, 11 and 12, the relation between the volume change and the equilibrium 
constant at constant temperature with change in pressure becomes evident: 100 
−RT ∂lnKa
∂P
= ΔV  (Eq. 13) 
Liquids are often practically incompressible due to tight packing of the species in solution. This is 
due to intermolecular repulsive forces in solution. In reality, liquids are slightly compressible, and 
pressure increase leads to small volume changes. At pressures <300-400 MPa, the volume changes 
with pressure are minimal (Quinlan and Reinhart, 2005). This means that small changes in pressure 105 
have a limited effect on the composition and thus the equilibrium in solution. 
 
2.3 Ionic strength 
Ions exhibit strong interactions in solution, resulting in deviation from ideal behavior. In eq. 2, Ka is 
expressed in terms of the concentrations of the reacting species. However, this is too simplistic and 110 
it is inadequate to describe the true nature of Ka this way, due to solutions deviating from ideal 







  (Eq. 14) 
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where a is the activity, and γ is the activity coefficient. By using the activity term, a more precise 
equilibrium constant can be determined. At low ionic strength, the activity coefficient of an ionic 115 
solution (γ) can be calculated from the Debye-Hückel equation: 
logγ =  −z2AI½  (Eq. 15) 
where A is a constant, z is the charge and I is the ionic strength. A and I can be calculated 
(Kennedy, 1990): 
A = 1.824 ∙ 106  ∙ (ϵT)−3/2 (Eq. 16) 120 
A depends on temperature and the dielectric constant ϵ of the solvent. The ionic strength (I) 
describes the intensity of the ion atmosphere of the entire solution (Kennedy, 1990): 
I = 1/2∑ z2C  (Eq. 17) 
The sum of charge (z) and concentration (C) refers to all of the various ions in the solution. The 
Debye-Hückel equation is valid at low ionic strength. Better estimates of the activity coefficient at 125 
higher ionic strength is possible by including terms for the effective radius of the ions or with 
empirical constants (Goldberg et al., 2002; Kennedy, 1990; Roy et al., 2006): 
logγ =  − Az
2√I
1+Ba˚√I
+ CI  (Eq. 18) 
where B is constant, a˚ is the ion size parameter, and C is an adjustable parameter based on curve-
fitting. As shown by these equations, the activity coefficient depends on the ionic strength, the 130 
charge and the temperature, thus making pKa dependent on ionic strength. 
 
3. Experimental determination of thermodynamic quantities pKa, ΔH, and ΔCp 
Some methods used to determine pKa include potentiometry, spectrometry, conductometry, 
solubility, NMR, electrochemical cells with and without liquid junctions and calorimetry (Babic et 135 
al., 2007; Goldberg et al., 2002; Nowak et al., 2015; Reijenga et al., 2013). By combining 
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experiments and thermodynamic equations, it is possible to determine how pKa depends on 
temperature, and thus also how to use this information during drug formulation and processing. 
 
The methods mentioned above are all widely used and accepted. However, a discussion of which 140 
techniques are superior is complex and beyond the scope of this work. Instead, interested readers 
are referred to papers such as Reijenga et al. (2013) and Babic et al. (2007) for descriptions of 
techniques and comparison between methods. It is worth noting though, that differences in results 
are seen between various experimental methods used to determine thermodynamic quantities. Also, 
there are a differences in how well results and experimental conditions are reported. Potentiometric 145 
titration is an inexpensive and simple technique (Reijenga et al., 2013), but results are often 
summarized and the experimental data and conditions are not always reported in full detail 
(Goldberg et al., 2002). For conductivity measurements, electrochemical cell setups, and 
calorimetric studies, the experimental conditions, the composition of solutions as well as the 
primary data are often reported, making it possible to recalculate the thermodynamic results based 150 
on these methods (Goldberg et al., 2002). By reporting experimental conditions and results more 
clearly, it enables recalculation of data (Goldberg et al., 2002). This provides an important tool in 
validating existing and potential thermodynamic models. 
 
4. Data selection 155 
During drug formulation and processing, it is important to choose a suitable buffer. For the present 
work some pharmaceutically relevant buffers have been selected, where the criteria for selecting 
buffers were 1) relevance for drug formulation, 2) availability of literature regarding 
thermodynamic quantities at various temperatures, pressure and ionic strength, and lastly 3) buffers 
with different chemical structure should be included to highlight any potential differences based on 160 
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Table 1. The table shows pKa, ΔH and ΔCp at 25˚C for selected buffers used regularly in the pharmaceutical industry. 
a(Goldberg et al., 2002). b(Nagai et al., 2008). cpK1 including aqueous CO2. na = data not available. 
Buffer  pKa ΔrH˚ (kJ mol-1) ΔrCp˚ (J K-1 mol-1) 
Acetatea  4.76 -0.41 -142 
Carbonatea pK1 3.60 na na 
 pK1.1c 6.35 9.15 -371 
 pK2 10.33 14.70 -249 
Citratea pK1 3.13 4.07 -131 
 pK2 4.76 2.23 -178 
 pK3 6.40 -3.38 -254 
Succinatea pK1 4.21 3.0 -121 
 pK2 5.64 -0.5 -217 
Phosphatea pK1 2.15 -8.0 -141 
 pK2 7.20 3.6 -230 
 pK3 12.33 16.0 -242 
Trisa  8.06 47.45 -59 
HEPESa pK1 3.00 na na 
 pK2 7.50 20.4 47 
MESa  6.27 14.8 5 
TAPSa  8.44 40.4 15 
Histidinea,b pK1 1.56 -2.3 na 
 pK2 6.07 29.5 176 
 pK3 9.34 43.8 -233 
Lysineb pK1 1.85 0.33 na 
 pK2 9.09 39.3 na 
 pK3 10.90 43.5 na 
Glutamateb pK1 2.19 -0.366 na 
 pK2 4.45 -0.798 na 




ΔH describes how the equilibrium constant depends on temperature. For ΔH close to 0, the 
equilibrium constant shows little variation with temperature as described by Eq. 8. ΔCp describes 
how ΔH depends on temperature. A ΔCp value close to 0 means that ΔH varies little with 
temperature. 
 170 
5. Pressure has a negligible effect on buffer pKa at pressures <100 MPa 
Theoretically, a small change in pressure will lead to minimal changes in Ka. For carboxylic acids 
such as acetate, succinate and citrate, the pKa decreases as pressure is increased (Hayert et al., 1999; 
Kumar, 2005; Quinlan and Reinhart, 2005). The decrease in pKa is relatively small. For acetic acid, 
a decrease of 0.1 pH units is observed when pressure is increased from 0.1 MPa to 25.3 MPa 175 
(Kumar, 2005), and a decrease of 0.2 pH units when pressure is increased to 100 MPa (Hayert et al., 
1999). Evidently, the reduction in pKa is minimal for these buffers, even when pressure changes 
significantly. 
 
Increase in pressure decreases the pKa of phosphate buffer (Hayert et al., 1999; Quinlan and 180 
Reinhart, 2005). Phosphate is slightly more sensitive to pressure changes than carboxylic acid 
buffers, and for the range 0.1-100 MPa pKa decreases by 0.3 pH units (Hayert et al., 1999). 
Phosphate buffer is increasingly more sensitive at higher pressures (Hayert et al., 1999). 
 
Tris buffers and biological buffers such as HEPES and MES also show sensitivity towards pressure. 185 
However, in contrast with carboxylic acid buffers, pKa increases with pressure (Hayert et al., 1999; 
Quinlan and Reinhart, 2005). The magnitude is similar to that of carboxylic acid buffers (Quinlan 
and Reinhart, 2005). Tris is thought to be almost pressure insensitive (Neuman et al., 1973). The 
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difference among the various groups of buffers is thought to be related to charges in the solution, as 
volume contractions occur due to packing of water molecules around the charged species (Hayert et 190 
al., 1999). 
 
It has been shown in several studies that the relationship between pKa and pressure is approximately 
linear for the pressure range of 0-200 MPa (Hayert et al., 1999; Li and Duan, 2007; Quinlan and 
Reinhart, 2005), thus making it possible to interpolate the change in pKa value for pressures 195 
relevant during pharmaceutical processing. During autoclaving, pressure changes occur for liquid 
systems as the pressure increases to around 0.304 MPa (3 atm) to obtain the sterilization 
temperature. The change in pressure during autoclaving corresponds to a decrease of 0.0005 pH 
units for acetic acid, so the influence of pressure on the pKa value during autoclaving can be 
regarded as negligible. Other pharmaceutical processes where pressure changes may be relevant 200 
include homogenization, lyophilization, liposome extrusion, and transfer of liquid between 
compounding vessels. During production of e.g., suspensions or emulsions, homogenization is often 
used. Thus, a pressure of 10 MPa (100 atm) may be applied. Under these conditions  the pKa of 
acetic acid decreases less than 0.04 pH units, which is still considered a small change. For high 
pressure homogenization, a pressure around 150-200 MPa can be applied, which will affect the  205 
pKa of most buffers by about 0.5 pH units. This can potentially influence the stability of drug 
formulations and should hence be considered. 
 
6. Temperature effect on pKa depends on chemical structure 
Carboxylic acid buffers are least affected by temperature changes (Goldberg et al., 2002; Karow et 210 
al., 2013; Mauger, 2017). The pKa values as a function of temperature for some carboxylic acid 
buffers are shown in figure 1, which is based on data reported by Goldberg et al. (2002).  
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An increase in temperature leads to a slight decreases in pKa values at low temperatures (0-50˚C), 
and pKa increases as the temperature exceeds 50˚C (Goldberg et al., 2002; Li and Duan, 2007). The 
changes are, however, small. The pKa of acetate decreases by 0.025 pH units from 0-25˚C, and 215 
increases 0.290 by pH units in the interval 25-125˚C (Goldberg et al., 2002). Similar small changes 
in pKa values are reported for many carboxylic acids - among others citrate and succinate (Goldberg 
et al., 2002; Quinlan and Reinhart, 2005). By curve fitting the data from figure 1, it is evident that 
there is a quadratic relationship between pKa and temperature for all three buffers. They fit a 
second-order polynomial function with similar quadratic coefficients, which means that the 220 
curvature is similar. Based on these data, the relationship between pKa and temperature is generally 
similar for the carboxylic acid buffers. Common for these buffers are also dissociation enthalpy 
close to 0 (Table 1) (Fukada and Takahashi, 1998; Goldberg et al., 2002). This means that pKa 
hardly changes with temperature. 
 225 
The dissociation of the first two protons of phosphate also have enthalpy values close to 0, and pKa 
changes only slightly with temperature (Karow et al., 2013; Mauger, 2017). In the temperature 
interval 25-125˚C, the pK1 of phosphate increases by 0.552 pH units (Goldberg et al., 2002). The 
enthalpy of the third proton dissociation of phosphate is larger and theoretically the temperature-
dependency would thus be greater. However, experimental data is only available up to 37˚C. The 230 
dissociation of carbonate has higher enthalpy changes, and thus also a greater temperature 
dependency. 
 
The buffer most sensitive to temperature changes is Tris (Goldberg et al., 2002; Mauger, 2017). The 
dissociation of Tris also shows the highest enthalpy change. Dissociation of biological buffers such 235 
as MES, HEPES and TAPS also exhibits high enthalpy changes (Table 1), and in general these 
15 
 
buffers are more sensitive to temperature changes compared to carboxylic acid buffers. Figure 2 
shows how the pKa values of some biological buffers vary with temperature. In contrast to 
carboxylic acid buffers, biological buffers and Tris buffer have decreasing pKa values as 
temperatures are increased (Roig et al., 1993; Roy et al., 2009; Roy et al., 2011). This indicates that 240 
increasing temperature does not favor ionization of the buffer. The pKa of Tris decreases 1.987 pH 
units in the interval 25-125˚C (Goldberg et al., 2002). A similar decrease in pKa is seen for TAPS, 
whereas MES and HEPES show slightly smaller decreases in pKa values (Fukada and Takahashi, 
1998).  
 245 
Other buffers with high dissociation enthalpy changes include the amino acids histidine and lysine. 
These buffers have high enthalpy values for the second and third dissociation represented by pK2 
and pK3. Histidine has a pK2 change of 0.46 pH units in the range 25-60˚C, and similarly, lysine has 
a pK2 change of 0.75 pH units (Nagai et al., 2008). For the amino acid glutamate, only pK3 is 
temperature sensitive (Gupta et al., 2013; Nagai et al., 2008). No experimental values for the pKa of 250 
amino acids at temperatures >60˚C could be found. However, it is possible to extrapolate these 
values to higher temperatures based on ΔH and ΔCp (Table 1) using Eq. 8 and 10. The extrapolation 
of pKa values for histidine, lysine, and glutamate are shown in figure 3. Figure 3 shows both 
experimental data from Nagai et al. (2008) and extrapolated pKa values for temperatures above 
60˚C. The extrapolation shows that pK2 and pK3 for lysine and pK3 for histidine are sensitive to 255 
temperature. The pK1 and pK2 values for glutamate are insensitive to temperature, and so is pK1 for 
lysine and pK2 for histidine. The extrapolation of pK3 value for glutamate does not fit well with the 
experimental data. The values are calculated based on ΔH and Eq. 8, and the fit would likely be 




There is a clear correlation between dissociation enthalpies close to 0 and lower sensitivity towards 
temperature increase. This has been described previously (Fukada and Takahashi, 1998; Karow et 
al., 2013). The selected biological buffers and Tris have high dissociation enthalpy values at 25˚C, 
and ΔCp is close to 0. This means the ΔH values will not change significantly when temperatures are 
increased, which means that these buffers are sensitive to temperature changes as seen in figure 2. 265 
For carboxylic acid buffers, small enthalpy changes at 25˚C are most commonly seen, and there is 
thus a small temperature dependency. The selected carboxylic acid buffers have high ΔCp values, 
which results in larger changes in dissociation enthalpy at higher temperatures, and this explains 
why pKa values of carboxylic acids become increasingly more sensitive as temperatures are 
increased (see figure 1). The carboxylic acid moiety of amino acids exhibits dissociation enthalpies 270 
close to 0, and these pKa values are insensitive to temperature changes (see figure 3).  By 
comparing pKa values of amino acids with the various functional groups in each amino acid, it 
becomes evident that the functional groups reflect the sensitivity towards temperature. Histidine and 
lysine have one carboxylic acid moiety each represented by pK1, and both moieties have low 
dissociation enthalpies. On the other hand, glutamic acid has two functional carboxylic acid 275 
moieties i.e., pK1 and pK2, and both of these moieties have low dissociation enthalpies. The two 
amino moieties of histidine and lysine have higher dissociation enthalpies, and are thus more 
sensitive to temperature changes (figure 3). The functional groups reflect the sensitivity towards 
temperature, as histidine and lysine, with only one carboxylic acid moiety, are more sensitive to 
changes in temperature compared to glutamic acid. Further, it is observed that buffers containing 280 
amino groups are very temperature dependent. The effect of temperature on the pKa values of 
buffers is linked to the chemical structure. This knowledge can be used to qualitatively predict the 




During drug formulation, processing and storage temperatures can vary. Storage temperatures are 285 
often as low as 5˚C, but may vary from country to country. In warmer climates, storage 
temperatures may be up to 30˚C. During processing such as autoclaving temperatures are up to 
130˚C. The pKa of Tris is 8.06 at 25˚C, and thus it has a buffering capacity in the range 7-9 at this 
temperature. As temperature is increased to 130˚C, pKa decreases to 6.07, and correspondingly the 
pH of the solution decreases by 2 pH units. Tris is considered to be the most temperature-sensitive 290 
buffer, and the above mentioned example was therefore based on this buffer. Also during 
homogenization of formulations, temperature can vary, which can affect the pKa. As the liquid is 
compressed, the temperature will rise 2-2.5˚C per 10 MPa. The pressure increase during 
homogenization is approximately 50 MPa, meaning the temperature will increase by 10-12.5˚C. 
During homogenization, this will correspond to a decrease in pKa of approximately 0.3 pH units for 295 
Tris buffer. However, during high pressure homogenization, the pressure increase is 100-200 MPa, 
and thus the temperature increase will be 20-50˚C. In addition to temperature rising with increasing 
pressure, the formulation is sometimes preheated prior to homogenization. The maximum 
temperature during high pressure homogenization can reach 140˚C, which would affect the pKa of 
buffers. As drug formulations highly depend on the regulation of pH, this is potentially a problem 300 
that should be incorporated into the formulation and process design. One way of doing this could be 
to use a flowchart (figure 4) that visualizes how temperature and pressure should be considered 
when selecting a suitable buffer. Altering the pKa of a system changes the pH of the solution, which 
influences the solubility and chemical stability of the product. Amino-containing buffers appear 
most sensitive to temperature changes, according to the data presented in this work. However, to 305 
evaluate other buffer species more closely, it is suggested to consider ΔH and ΔCp of the reaction. If 
ΔH is known, it is possible to predict the variation of pKa with temperature over small temperature 
intervals by using Eq. 8. By knowing ΔH and ΔCp, it is possible to make more accurate predictions 
18 
 
for pKa across a wider range of temperatures using Eq. 10. These two parameters should be 
considered and used as a guide during drug formulation or processing, as illustrated in figure 4. 310 
 
The temperature-dependency is sometimes crucial for selecting a suitable buffer, and in such 
situations a carboxylic acid buffer would be preferred. However, there might be situations where 
carboxylic acid buffers are not suitable due to unwanted interactions. Alternatively, it should be 
possible to use a mixture of buffers to obtain a suitable system that is less affected by temperature. 315 
In a study by Quinland and Reinhart (2005), it was proposed that insensitivity of pKa values to 
pressure might be achieved by mixing two buffers; one with increasing pKa as pressure is increased, 
and one with decreasing pKa as pressure is increased. Glutamate is a buffer that contains two 
carboxylic acid groups and an amino group, and the amino acid moiety is less affected by changes 
in temperature compared to other amino-containing buffers. Thus, a mixture of a biological or Tris 320 
based buffer with carboxylic acid buffer could lead to a buffer less sensitive to changes in 
temperature than biological buffers by themselves. However, it would be necessary to verify this 
experimentally. 
 
7. Influence of ionic strength on pKa of selected buffers 325 
The ionic strength of a solution describes the interactive forces and distances between the ions in 
the solution. Ionic strength can be increased by increasing the concentration of existing components 
or by adding ionic compounds. It is possible to keep the ionic strength practically constant by 
having a large concentration of background electrolytes (e.g. buffer) compared to the ionic 
contribution of added species (Ferra et al., 2011). As described previously, changes in ionic strength 330 
affect the activity coefficient, and will thus lead to changes in pKa values. For carboxylic acid 
buffers, the pKa decreases with increasing ionic strength until a minimum is reached; further 
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increase of the ionic strength leads to an increase in pKa. The minimum for carboxylic acids is 
reached for ionic strength around 0.42-1.5 mol/kg. The pKa of acetate decreases around 0.3 pH units 
as ionic strength is increased in the interval 0-0.5 mol/kg at 25˚C (Ferra et al., 2011; Harned et al., 335 
1937). Similar decreases in pKa are seen for citrate and succinate in the interval 0-1 mol/kg at 25˚C 
(Bénézeth et al., 1997; Kettler et al., 1995). The pKa of carbonate also decreases by a  similar 
magnitude in the interval 0-1.5 mol/kg (He and Morse, 1993; Millero et al., 2007). Phosphate shows 
a relationship between pKa and ionic strength that is similar to that of carboxylic acid buffers. The 
pKa decreases for ionic strength 0-3 mol/kg, and increases for higher ionic strength (Hershey et al., 340 
1989). 
 
Tris behaves differently from carboxylic acid buffers when ionic strength is increased, as was also 
seen for the pKa-temperature relationship. The pKa of Tris increases by about 0.2 pH units in the 
interval 0-1 mol/kg at 25˚C (Izaguirre and Millero, 1987; Palmer and Wesolowski, 1987). An 345 
increase in pKa with increasing ionic strength is also observed for biological buffers (Roig et al., 
1993; Roy et al., 2002; Wesolowski and Palmer, 1989).  
 
It is evident that the structure of the buffers dictates how they are affected by ionic strength. This is 
similar to what is observed for the temperature effect on buffer pKa. However, whereas the pKa of 350 
Tris and biological buffers decreases with temperature, pKa values increase with ionic strength. For 
carboxylic acid buffers, the effect of ionic strength on pKa is interval specific. Manipulating ionic 
strength can be exploited during drug formulation to increase chemical stability or improve 
solubility without having to change the buffer system. Increasing the ionic strength of Tris buffer 
will increase the pKa, and thus alter the appropriate range of the buffer. At 0 mol/kg ionic strength 355 
the pKa of Tris is 8.06, but at 2 mol/kg, the pKa increases to 8.41, thus slightly changing the 
20 
 
appropriate buffer range to 7.5-9.5. Exploiting the variation of pKa has the potential to make buffers 
more versatile, as a relevant pKa value is essential in choosing the appropriate buffer system. 
 
As described previously, the thermodynamic equilibrium constant is defined by the concentration 360 
and the activity coefficient, thus this should be accounted for when reporting pKa values. By 
adjusting the pKa values to 0 mol/kg ionic strength, it would become easier to compare pKa values 
reported in different studies. In many cases, the activity coefficients are unknown, but these can be 
estimated by the Debye-Hückel model or similar models. The biggest challenge in doing so is 
choosing the correct model, as the Debye-Hückel equation is valid at low ionic strength, and the 365 
inclusion of empirical constants is needed to account for a more complex ion environment and 
specific interactions. Extending and understanding the ion activity models are a field of study of its 
own, but accurate reporting of thermodynamic pKa values will make it easier to compare values 
obtained in different studies. 
 370 
8. Role of organic co-solvents in relation to buffer pKa 
Organic co-solvents have a lower dielectric constant than water. The dielectric constant is a 
measure of the polarity of a solvent, and thus the addition of organic co-solvents will reduce the 
overall polarity of a solution. The concentration of organic co-solvent is often varied during pre-
formulation to find a suitable concentration, but during later pharmaceutical processing, the 375 
concentration will be constant. From Eq. 15 and 16, it can be seen how the activity coefficient 
depends on the dielectric constant. Reduction in the dielectric constant results in a decreased 
polarity. Changes in the polarity of the solution will lead to changes in pKa values (Avdeef et al., 
1999; Yalkowsky, 1999; Yasuda, 1959). The variation in pKa depends on the fraction of the co-
solvent, the pH of the solution and the buffer species (Subirats et al., 2007). For carboxylic acids, 380 
21 
 
addition of co-solvents will increase the pKa values (Williams et al., 2013). The magnitude of the 
increase depends on the polarity and amount of the co-solvent. The pKa of acetic acid increases 
from 4.76 to 5.89 in a 50:50 mixture of water-DMSO (Yalkowsky, 1999). Also in a 50:50 mixture 
of water-ethanol is a changed in the pKa value of acetic acid observed, where it has been reported to 
be 5.62 (Yalkowsky, 1999). The pKa of phosphate buffer also increases as the polarity of the 385 
solvent decreases (Yalkowsky, 1999). 
 
The pKa of Tris decreases from 8.06 to 7.66 in a 50:50 mixture of water-DMSO (Yalkowsky, 
1999). Biological buffers, i.e. HEPES, MES TAPS etc., show a similar decrease in pKa values by 
addition of organic co-solvents. In general, the effect on pKa values by co-solvents is smaller with 390 
Tris and biological buffers compared to carboxylic acid buffers. In general, when adding co-
solvents, the pKa value of a base is decreased by half as much as the pKa value of an acid is 
increased (Yalkowsky, 1999). 
 
The acidity of the buffer dictates the effect of added organic co-solvents. In drug formulation and 395 
processing, addition of organic co-solvents can be a necessity. Organic co-solvents are used to 
overcome issues with low aqueous solubility (Avdeef, 1998). This strategy is often applied to non-
polar compounds which are practically insoluble in water (Williams et al., 2013). The amount of 
organic co-solvent needed depends on the insoluble compound and the desired concentration. The 
effects of an organic co-solvent on the pKa of the buffer can be minimized by using a small amount 400 
of organic co-solvent and choosing a co-solvent with a dielectric constant close to that of water. 
 
It is possible to extrapolate the obtained pKa values to zero organic solvent content (Avdeef et al., 
1999; Rived et al., 2001). Several extrapolation equations exist, but the most popular relates the 
22 
 
dielectric constant to the pKa value through a linear relationship (Ruiz et al., 2005). The pKa value 405 
must be measured at various water-methanol concentrations to obtain empirical constants that can 
be used for the extrapolation. A linear relationship is seen for 0-60 % methanol content. More 
advanced models also exist. 
 
9. Summary 410 
The pH of a buffer solution is an important characteristic during drug formulation and processing, 
and it depends on the buffer pKa. Altering the temperature affects the buffer pKa as described by the 
van’t Hoff equations, and the effect on pKa can be predicted based on ΔH and ΔCp. The effect of 
temperature depends on the functional groups of the buffer. Carboxylic acid buffers and carboxylic 
acid moieties in amino acids have a low temperature-dependency, while amine containing buffers 415 
are very temperature-dependent. Pressure changes within an interval of 0-100 MPa result in 
practically no changes in pKa values for any of the buffer species. At higher pressures, changes in 
pKa up to 0.5 pH units should be expected. 
 
Altering ionic strength or the polarity of the solvent can be used to increase solubility of poorly 420 
soluble compounds, but these changes will affect the pKa value due to the effect on the activity 
coefficient. The ionic strength affects the pKa value in an interval-dependent manner depending on 
the structure of the buffer. Co-solvents reduce the polarity of the solvent resulting in decreased pKa 
values for bases and increased pKa values for acids. 
 425 
The effect on pKa can be exploited to increase chemical stability. However, changes in pKa values 
can also present challenges during drug formulation and processing, i.e., during autoclaving, storage 
or homogenization where temperature or pressure increase. A carboxylic acid buffer or phosphate 
23 
 
buffer would be most suited to avoid changes in pKa value of the buffer due to temperature changes. 
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Figure 1: pKa values as function of temperature (˚C) for selected carboxylic acid buffers; acetate, 
citrate, and succinate. The pKa values are almost invariant over the temperature range of 0-125˚C. 
The plot is generated based on experimental data available from Goldberg et al. (2002). 550 
 
Figure 2: pKa values as a function of temperature (˚C) for Tris buffer and some biological buffers; 
MES, TAPS, and HEPES. The pKa values for all buffers decrease as temperature increases. This 
plot is based on experimental data available from Goldberg et al. (2002) and Fukada and Takahashi 
(1998). 555 
 
Figure 3: pKa values as a function of temperature (˚C) for the amino acids; lysine, histidine, and 
glutamate. ( ̶̶ ̶ ): pK1. (̶ ̶ ̶ ): pK2. ( ̶ ̶ ̶ ): pK3. The open data points from 0-60˚C are experimental 
data from Nagai et al. (2008). The filled data points from 75-125˚C are extrapolated based on ΔH 
and ΔCp in Table 1 and Eq. 8 or 10. 560 
 
Figure 4: Flowchart illustrating how temperature and pressure should be considered during the 
selection of a suitable buffer for pharmaceutical processing. 
